First Time Loading...

Xvivo Perfusion AB
STO:XVIVO

Watchlist Manager
Xvivo Perfusion AB Logo
Xvivo Perfusion AB
STO:XVIVO
Watchlist
Price: 381.5 SEK 1.46% Market Closed
Updated: May 9, 2024
Section:
 

Relative Value

The Relative Value of one XVIVO stock under the Base Case scenario is 166.42 SEK. Compared to the current market price of 381.5 SEK, Xvivo Perfusion AB is Overvalued by 56%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

XVIVO Relative Value
Base Case
166.42 SEK
Overvaluation 56%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

18.7
P/S
P/S
Price to Sales
18.7
vs History
63
vs Industry
9
Median 3Y
18.5
Median 5Y
20.9
Industry
2.4
Forward
14.5
More Details
119.7
P/E
P/E
Price to Earnings
119.7
vs History
63
vs Industry
3
Median 3Y
261.5
Median 5Y
284.8
Industry
23.4
Forward
159
More Details
199.3
P/OCF
P/OCF
Price to OCF
199.3
vs History
39
vs Industry
1
Median 3Y
145.7
Median 5Y
157.2
Industry
15.5
More Details
199.3
P/FCFE
P/FCFE
Price to FCFE
199.3
vs History
34
vs Industry
2
Median 3Y
-68.4
Median 5Y
95
Industry
23.2
More Details
6
P/B
P/B
Price to Book Value
6
vs History
61
vs Industry
13
Median 3Y
5.4
Median 5Y
6.3
Industry
2.3
More Details
17.9
EV/S
EV/S
Enterprise Value to Sales
17.9
vs History
65
vs Industry
8
Median 3Y
18
Median 5Y
20
Industry
2.5
Forward
13.9
More Details
24.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
24.2
vs History
65
vs Industry
8
Median 3Y
24.7
Median 5Y
27.2
Industry
5.3
More Details
962.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
962.7
vs History
1
vs Industry
0
Median 3Y
-210.7
Median 5Y
103.2
Industry
12.6
Forward
64
More Details
962.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
962.7
vs History
15
vs Industry
0
Median 3Y
-210.7
Median 5Y
354.7
Industry
17.2
Forward
106.5
More Details
191.1
EV/OCF
EV/OCF
Enterprise Value to OCF
191.1
vs History
39
vs Industry
1
Median 3Y
135.5
Median 5Y
151.9
Industry
15.3
More Details
191.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
191.1
vs History
34
vs Industry
2
Median 3Y
-71.6
Median 5Y
90.9
Industry
19.8
More Details
6.6
EV/IC
EV/IC
Enterprise Value to IC
6.6
vs History
57
vs Industry
13
Median 3Y
5.5
Median 5Y
7.2
Industry
2
More Details

Multiples Across Competitors

XVIVO Competitors Multiples
Xvivo Perfusion AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Xvivo Perfusion AB
STO:XVIVO
12B SEK 18.7 119.7 962.7 962.7
JP
Hoya Corp
TSE:7741
6.4T JPY 8.5 38.2 23.2 28.6
CH
Alcon AG
SIX:ALC
36B CHF 4.2 40.7 18.1 36.8
DK
Coloplast A/S
CSE:COLO B
190B DKK 7.6 39 25.7 29.8
US
Align Technology Inc
NASDAQ:ALGN
20.6B USD 5.3 44.5 24.4 29.7
US
Cooper Companies Inc
NYSE:COO
18.3B USD 5 62.9 22.9 39
KR
HLB Inc
KOSDAQ:028300
13.8T KRW 322.1 -73.1 -119.1 -109.9
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
61.5B CNY 15.7 37.2 32.6 32.6
UK
ConvaTec Group PLC
LSE:CTEC
5.4B GBP 3.1 51.3 46.9 50.9
US
DENTSPLY SIRONA Inc
NASDAQ:XRAY
5.8B USD 1.5 -60.8 11.5 25.7
US
Lantheus Holdings Inc
NASDAQ:LNTH
5.2B USD 3.8 11.2 9.4 10.6

See Also

Summary
XVIVO intrinsic value, competitors valuation, and company profile.
DCF Valuation
XVIVO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
XVIVO stock valuation using valuation multiples.
Wall Street Estimates
XVIVO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
XVIVO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 135,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.